Cooper Companies | COO - Zinsaufwendungen Für Schuld

Aktienkurs
71.56
Täglich Wechseln
0.10 0.14%
Monatlich
-2.97%
Jährlich
-7.62%
Q2 Prognose
68.06




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 42M 2M 2025-12
Align Technology USD 2M 660K 2023-03
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Bausch Health Companies USD 412M 53M 2025-09
Baxter International USD 58M 14M 2025-09
Bayer EUR 675M 87M 2025-12
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
Dentsply International USD 22M 1000K 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Globus Medical USD 17K 5.1B 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
Hologic USD 27.6M 1000K 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
J&J USD 18M 290M 2025-09
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Novartis USD 281M 8M 2025-09
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 800K 799K 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12